Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
  • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
  • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
  • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D237/22—Nitrogen and oxygen atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
  • C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/50—Pyridazines; Hydrogenated pyridazines
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/08—Bronchodilators
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
  • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/08—Vasodilators for multiple indications
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
  • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
  • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Medicinal Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Cardiology (AREA)
• Heart & Thoracic Surgery (AREA)
• Epidemiology (AREA)
• Hematology (AREA)
• Diabetes (AREA)
• Pulmonology (AREA)
• Hospice & Palliative Care (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Saccharide Compounds (AREA)
• Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
• Hydrogenated Pyridines (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=10554924

Family Applications (1)

Country Status (31)

Families Citing this family (35)

Family Cites Families (9)

• 1984
  • 1984-01-13 GB GB848400863A patent/GB8400863D0/en active Pending
• 1985
  • 1985-01-02 JO JO19851351A patent/JO1351B1/en active
  • 1985-01-07 ZW ZW3/85A patent/ZW385A1/xx unknown
  • 1985-01-07 CA CA000471594A patent/CA1251209A/en not_active Expired
  • 1985-01-08 DK DK009185A patent/DK162519C/da not_active IP Right Cessation
  • 1985-01-09 PH PH31697A patent/PH22136A/en unknown
  • 1985-01-10 IL IL74031A patent/IL74031A/xx unknown
  • 1985-01-10 GR GR850068A patent/GR850068B/el unknown
  • 1985-01-10 DD DD85272500A patent/DD231350A5/de not_active IP Right Cessation
  • 1985-01-10 ES ES539446A patent/ES8607949A1/es not_active Expired
  • 1985-01-10 PT PT79819A patent/PT79819B/pt not_active IP Right Cessation
  • 1985-01-10 CS CS85202A patent/CS248731B2/cs unknown
  • 1985-01-11 WO PCT/GB1985/000014 patent/WO1985003076A1/en not_active Ceased
  • 1985-01-11 IE IE69/85A patent/IE57969B1/en not_active IP Right Cessation
  • 1985-01-11 FI FI850140A patent/FI850140A7/fi not_active Application Discontinuation
  • 1985-01-11 NO NO850129A patent/NO850129L/no unknown
  • 1985-01-11 NZ NZ210816A patent/NZ210816A/en unknown
  • 1985-01-11 HU HU85109A patent/HU193591B/hu not_active IP Right Cessation
  • 1985-01-11 AU AU37611/85A patent/AU572252B2/en not_active Ceased
  • 1985-01-11 AT AT85300196T patent/ATE37179T1/de active
  • 1985-01-11 DE DE8585300196T patent/DE3564941D1/de not_active Expired
  • 1985-01-11 PL PL1985251516A patent/PL147123B1/pl unknown
  • 1985-01-11 JP JP60003912A patent/JPS60158181A/ja active Pending
  • 1985-01-11 EP EP85300196A patent/EP0150937B1/de not_active Expired
  • 1985-01-11 ZA ZA85251A patent/ZA85251B/xx unknown
  • 1985-01-12 KR KR1019850000179A patent/KR920006781B1/ko not_active Expired
  • 1985-01-14 US US06/690,911 patent/US4654342A/en not_active Expired - Fee Related
  • 1985-04-01 CN CN198585101722A patent/CN85101722A/zh active Pending
  • 1985-09-12 SU SU853958649A patent/SU1396963A3/ru active
  • 1985-09-12 RO RO85120090A patent/RO92607A/ro unknown
  • 1985-12-05 ES ES549629A patent/ES8703846A1/es not_active Expired
• 1986
  • 1986-05-14 ES ES554965A patent/ES8706645A1/es not_active Expired
• 1987
  • 1987-06-02 MY MYPI87000758A patent/MY100124A/en unknown
• 1988
  • 1988-05-09 JP JP63113411A patent/JPS63313776A/ja active Pending
  • 1988-05-09 JP JP63113410A patent/JPS63313775A/ja active Pending
  • 1988-10-21 CA CA000581012A patent/CA1260471A/en not_active Expired

Also Published As

Similar Documents